Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 29.65
0.00 (0.00%)
Jul 30, 2026, 9:59 AM CST
[Name] Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,056 | 1,056 | 690.03 | 753.33 | 712.53 | 441.08 |
Revenue Growth | 32.31% | 53.07% | -8.40% | 5.73% | 61.54% | 49.12% |
Gross Profit Gross Profit Growth | 222.55 | 222.55 | 74.28 | 153.09 | 205.79 | 125.49 |
Operating Income Operating Income Growth | 110.87 | 110.87 | -49.35 | 25.78 | 67.76 | -1.11 |
Net Income Net Income Growth | 96.32 | 96.32 | -53.54 | 15.31 | 51.55 | -8.3 |
Earnings Per Share EPS Growth | 2.61 | 2.61 | -1.46 | 0.42 | 1.55 | -0.25 |
EPS Growth | - | - | - | -72.90% | - | - |
Revenue by Segment
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Health Food Products Department Health Food Products Department Growth | 879.09 | 879.09 | 554.46 | 492.78 | 494.24 | 327.79 |
Western Medicine Section Western Medicine Section Growth | 177.12 | 177.12 | 135.57 | 260.55 | 218.29 | 113.29 |
Total Total Growth | 1,056 | 1,056 | 690.03 | 753.33 | 712.75 | 441.08 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 152.62 | 152.62 | 102.8 | 122.57 | 71.96 | 72.5 |
Total Debt Total Debt Growth | 422.03 | 422.03 | 460.8 | 490.36 | 523.11 | 565.99 |
Net Cash (Debt) Net Cash Growth | -269.41 | -269.41 | -357.99 | -367.79 | -451.15 | -493.49 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.29 | -7.29 | -9.79 | -10.06 | -13.54 | -14.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 90.06 | 90.06 | 46.21 | 62.5 | 91.65 | 42.36 |
Capital Expenditures CapEx Growth | -18.24 | -18.24 | -18 | -62.05 | -19.53 | -40.98 |
Free Cash Flow Free Cash Flow Growth | 71.81 | 71.81 | 28.21 | 0.45 | 72.13 | 1.38 |
Free Cash Flow Growth | 135.82% | 154.56% | 6197.10% | -99.38% | 5118.96% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 21.07% | 21.07% | 10.76% | 20.32% | 28.88% | 28.45% |
Operating Margin | 10.50% | 10.50% | -7.15% | 3.42% | 9.51% | -0.25% |
Pretax Margin | 9.92% | 9.92% | -7.55% | 2.54% | 9.01% | -2.34% |
Profit Margin | 9.12% | 9.12% | -7.76% | 2.03% | 7.23% | -1.88% |
FCF Margin | 6.80% | 6.80% | 4.09% | 0.06% | 10.12% | 0.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | - | 0.250 | 0.150 |
Dividend Per Share Growth | 0% | - | - | 66.67% | - |
Dividend Yield | 1.69% | 1.64% | - | 0.73% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.36 | 11.82 | - | 82.75 | - | - |
P/FCF Ratio | 15.11 | 15.85 | 28.42 | 2827.58 | - | - |
PS Ratio | 1.03 | 1.08 | 1.16 | 1.68 | - | - |